Patent Assignment
Reel/Frame 069341/0832
Patent Security Agreement
Recorded: 2024-11-12
Pages: 63
Assignor
GERON CORPORATION
Executed: 2024-11-01
Assignee
BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(68)
Synthesis of Protected 3'-amino Nucleoside Monomers
Application:
18/490,328 →
Publication:
US 2024/0300992
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
Application:
18/491,658 →
Publication:
US 2024/0318232
Guanine Analogs as Telomerase Substrates and Telomere Length Affectors
Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
Application:
17/864,129 →
Publication:
US 2023/0183704
Oligonucleotide Compositions and Methods of Making the Same
Application:
18/405,775 →
Publication:
US 2025/0011359
Subcutaneous Telomerase Inhibitor Compositions and Methods for Using Same
Application:
17/376,517 →
Publication:
US 2022/0168403
Combination Treatment for Hematological Cancers
Application:
17/670,278 →
Publication:
US 2022/0168333
Process for Preparing Imetelstat
Application:
18/487,919 →
Publication:
US 2024/0199672
Process for Preparing Imetelstat
Methods of Treating Myelodysplastic Syndrome
Methods of Identifying Patients Likely to Benefit from Treatment with a Telomerase Inhibitor
Application:
16/525,026 →
Publication:
US 2020/0063214
Methods of Treating Myelodysplastic Syndrome
Crystalline Solids of 3-Palmitoyl-Amido-1,2-Propanediol and 3-Palmitoyl-Amido-2-Hydroxy-1-Dimethoxytriphenylmethylether-Propane and Methods of Making and Using the Same
Application:
18/635,809 →
Publication:
US 2024/0360074
Use of a Janus Kinase Inhibitor and a Telomerase Inhibitor for the Treatment of Myeloproliferative Neoplasms
Telomerase Inhibitor Compounds
Application:
18/436,936 →
Publication:
US 2024/0343713
Title Not Available
Application:
63/680,925 →
Methods of Treating Myelodysplastic Syndrome and Monitoring the Treatment
Application:
63/606,256 →
Methods of Treating Myelodysplastic Syndrome and Monitoring the Treatment
Application:
18/394,773 →
Publication:
US 2024/0285773
Modified Oligonucleotides for Telomerase Inhibition
Modified Oligonucleotides for Telomerase Inhibition
Modified Oligonucleotides for Telomerase Inhibition
Modified Oligonucleotides for Telomerase Inhibition
Modified Oligonucleotides for Telomerase Inhibition
Rna Amidates and Thioamidates for Rnai
Rna Amidates and Thioamidates for Rnai
Rna Amidates and Thioamidates for Rnai
Synthesis of Protected 3'-Amino Nucleoside Monomers
Synthesis of Protected 3'-Amino Nucleoside Monomers
Synthesis of Protected 3'-Amino Nucleoside Monomers
Synthesis of Protected 3'-Amino Nucleoside Monomers
Synthesis of Protected 3'-Amino Nucleoside Monomers
Cns-Tumor Treatment Method and Composition
Compounds Having Anti-Adhesive Effects on Cancer Cells
Compounds Having Anti-Adhesive Effects on Cancer Cells
Treatment of Carcinomas with a Combination of Egf-Pathway and Telomerase Inhibitors
Combined Telomerase Inhibitor and Gemcitabine for the Treatment of Cancer
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
Method for Identification of Sensitivity of a Patient to Telomerase Inhibition Therapy
Method of Detecting and Assaying Telomerase Activity of Telomerase Bound by Anti-Telomerase Antibodies
Telomere Length Measurement in Formalin-Fixed, Paraffin Embedded (FFPE) Samples by Quantitative PCR
Guanine Analogs as Telomerase Substrates and Telomere Length Affectors
Guanine Analogs as Telomerase Substrates and Telomere Length Affectors
Guanine Analogs as Telomerase Substrates and Telomere Length Affectors
Guanine Analogs as Telomerase Substrates and Telomere Length Affectors
C-Myc Antisense Oligonucleotides and Methods for Using the Same to Treat Cell-Proliferative Disorders
C-Myc Antisense Oligonucleotides and Methods for Using the Same to Treat Cell-Proliferative Disorders
Diagnostic Markers for Treating Cell Proliferative Disorders with Telomerase Inhibitors
Diagnostic Markers for Treating Cell Proliferative Disorders with Telomerase Inhibitors
Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms
Phosphorodiamidate Backbone Linkage for Oligonucleotides
Phosphorodiamidate Backbone Linkage for Oligonucleotides
Oligonucleotide Compositions and Methods of Making the Same
Oligonucleotide Compositions and Methods of Making the Same
Oligonucleotide Compositions and Methods of Making the Same
Oligonucleotide Compositions and Methods of Making the Same
Methods of Polynucleotide Preparation Using Multivalent Cation Salt Compositions
Methods of Polynucleotide Preparation Using Multivalent Cation Salt Compositions
Combination Treatment for Hematological Cancers
Amorphous Solid Succinylated 3-(Fatty Acid Amido)-2-Hydroxy-1-(Protected Hydroxy)-Propane Salts and Methods of Making the Same
Amorphous Solid Succinylated 3-(Fatty Acid Amido)-2-Hydroxy-1-(Protected Hydroxy)-Propane Salts and Methods of Making the Same
Crystalline Solids of 3-Palmitoyl-Amido-1,2-Propanediol and 3-Palmitoyl-Amido-2-Hydroxy-1-Dimethoxytriphenylmethylether-Propane and Methods of Making and Using the Same
Cancer Treatment by Combined Inhibition of Proteasome and Telomerase Activities
Improved Process for Preparing Imetelstat
Amorphous Solid Succinylated 3-(Fatty Acid Amido)-2-Hydroxy-1-(Protected Hydroxy)-Propane Salts and Methods of Making the Same
PCT:
PCT/US2020/057115 ↗
Crystalline Solids of 3-Palmitoyl-Amido-1,2-Propanediol and 3-Palmitoyl-Amido-2-Hydroxy-1-Dimethoxytriphenylmethylether-Propane and Methods of Making and Using the Same
PCT:
PCT/US2020/057122 ↗
Telomerase Inhibitor Compounds
PCT:
PCT/US2024/015024 ↗
Methods of Treating Myelodysplastic Syndrome and Monitoring the Treatment
PCT:
PCT/US2023/085720 ↗
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 9, 2004
From: GRYAZNOV, SERGEI; PONGRACZ, KRISZTINA
To: GERON CORPORATION
Reel/Frame 015787/0660 →
Assignment of Assignor's Interest
Mar 11, 2015
From: GRYAZNOV, SERGEI; PONGRACZ, KRISZTINA
To: GERON CORPORATION
Reel/Frame 035143/0574 →
Assignment of Assignor's Interest
Jul 30, 2015
From: GRYAZNOV, SERGEI; PONGRACZ, KRISZTINA
To: GERON CORPORATION
Reel/Frame 036221/0245 →
Assignment of Assignor's Interest
Jul 30, 2015
From: GRYAZNOV, SERGEI; PONGRACZ, KRISZTINA
To: GERON CORPORATION
Reel/Frame 036221/0260 →
Assignment of Assignor's Interest
Jul 19, 2019
From: JANSSEN BIOTECH, INC.
To: GERON CORPORATION
Reel/Frame 049807/0568 →
Assignment of Assignor's Interest
Dec 7, 2020
From: RIZO, ALEKSANDRA; BUSSOLARI, JACQUELINE CIRILLO
To: JANSSEN BIOTECH, INC
Reel/Frame 054568/0699 →
Assignment of Assignor's Interest
Mar 1, 2021
From: BUSSOLARI, JACQUELINE CIRILLO; HUANG, FEI
To: GERON CORPORATION
Reel/Frame 055443/0205 →
Assignment of Assignor's Interest
May 12, 2021
From: BUSSOLARI, JACQUELINE CIRILLO; HUANG, FEI; RIZO, ALEKSANDRA
To: GERON CORPORATION
Reel/Frame 056219/0142 →
Assignment of Assignor's Interest
Jan 20, 2022
From: HUANG, FEI
To: GERON CORPORATION
Reel/Frame 058709/0039 →
Assignment of Assignor's Interest
Jan 26, 2022
From: WANG, XIAOLI
To: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Reel/Frame 058781/0735 →
Assignment of Assignor's Interest
Mar 3, 2022
From: KAPUR, ANIL; MURPHY, PATRICK
To: GERON CORPORATION
Reel/Frame 059158/0863 →
Assignment of Assignor's Interest
Aug 4, 2022
From: JANSSEN BIOTECH, INC.
To: GERON CORPORATION
Reel/Frame 060719/0857 →
Assignment of Assignor's Interest
Aug 4, 2022
From: HUANG, FEI; RUSBULDT, JOSHUA J.; RIZO, ALEKSANDRA
To: JANSSEN BIOTECH, INC.
Reel/Frame 060719/0977 →
Assignment of Assignor's Interest
Sep 7, 2022
From: GRYAZNOV, SERGEI M.; PRUZAN, RONALD A.; PONGRACZ, KRISZTINA
To: GERON CORPORATION
Reel/Frame 061012/0384 →
Assignment of Assignor's Interest
Oct 14, 2022
From: STUART, MONIC J.; KELSEY, STEPHEN
To: GERON CORPORATION
Reel/Frame 061427/0148 →
Assignment of Assignor's Interest
Sep 1, 2023
From: GERON CORPORATION
To: HALOZYME, INC.; GERON CORPORATION
Reel/Frame 064779/0071 →
Assignment of Assignor's Interest
Dec 21, 2023
From: FELLER, FAYE; HUANG, FEI
To: GERON CORPORATION
Reel/Frame 065929/0353 →
Assignment of Assignor's Interest
May 9, 2024
From: FELLER, FAYE; HUANG, FEI
To: GERON CORPORATION
Reel/Frame 067364/0327 →
Assignment of Assignor's Interest
Jun 3, 2024
From: KHERA, MANOJ KUMAR; SONI, AJAY
To: GERON CORPORATION
Reel/Frame 067601/0586 →
Assignment of Assignor's Interest
Jun 4, 2024
From: JANSSEN PHARMACEUTICA NV
To: GERON CORPORATION
Reel/Frame 067615/0287 →
Assignment of Assignor's Interest
Jun 4, 2024
From: MUSLEHIDDINOGLU, JALE; GALA, DINESH; ALBANEZE-WALKER, JENNIFER E.
To: JANSSEN PHARMACEUTICA NC
Reel/Frame 067615/0208 →
Corrective Assignment to Correct the the Name of the Assignee Previously Recorded at Reel: 67615 Frame: 208. Assignor(S) Hereby Confirms the Assignment.
Jun 6, 2024
From: MUSLEHIDDINOGLU, JALE; GALA, DINESH; ALBANEZE-WALKER, JENNIFER E.
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 068232/0676 →
Assignment of Assignor's Interest
Jul 11, 2024
From: JANSSEN BIOTECH, INC.
To: GERON CORPORATION
Reel/Frame 067961/0577 →
Assignment of Assignor's Interest
Jul 11, 2024
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN BIOTECH, INC.
Reel/Frame 068283/0181 →
Assignment of Assignor's Interest
Jul 11, 2024
From: ALBANEZE-WALKER, JENNIFER E.
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 068281/0755 →